Corrigendum to “Methyl helicterte ameliorates liver fibrosis by regulating miR-21-mediated ERK and TGF-β1/Smads pathways”. [Int. Immunopharmacol. 66 (2019) 41–51]

Quanfang Huang(Guangxi University of Chinese Medicine), Xing Lin(Guangxi Medical University), Renbin Huang(Guangxi Medical University), Min He(Jiangxi University of Traditional Chinese Medicine), Facheng Bai(Guangxi Medical University), Jinlan Nie(Guangxi Medical University), Xiaolin Zhang(Peking University), Yuanyuan Wei(Guangxi Medical University), Zhongpeng Lu(NYU Langone Health), Shujuan Wen(Guangxi Medical University), Jinbin Wei(China Tobacco)
International Immunopharmacology
December 17, 2019
Cited by 2


Related Papers